MyFinsight
Home
Blog
About
Contact
Download
Download image
Revenue, net
$38,728K
(-17.47%↓ Y/Y)
Gross profit
$24,130K
(-19.37%↓ Y/Y)
Cost of revenue
$14,598K
(-14.13%↓ Y/Y)
Operating income from
continuing operations
$4,084K
(-49.63%↓ Y/Y)
Total operating
expenses
$20,046K
(-8.12%↓ Y/Y)
(benefit) provision for
income taxes
-$21,210K
(-530350.00%↓ Y/Y)
Income from continuing
operations before tax
$3,774K
(-45.70%↓ Y/Y)
Note payable
interest expense
$168K
(-73.12%↓ Y/Y)
Other expense, net
-$142K
(-128.46%↓ Y/Y)
Sales and marketing
$9,924K
(-14.85%↓ Y/Y)
General and
administrative
$9,480K
(-0.06%↓ Y/Y)
Research and development
$642K
(-5.03%↓ Y/Y)
Income from continuing
operations
$24,984K
(259.69%↑ Y/Y)
Net income
$24,575K
(266.68%↑ Y/Y)
Loss from
discontinued operations, net...
-$409K
(-67.62%↓ Y/Y)
Net income
attributable to common...
$24,575K
(293.96%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
INTERPACE BIOSCIENCES, INC. (IDXG)
INTERPACE BIOSCIENCES, INC. (IDXG)